PTC's revenues fell to $806.8 million in 2024, with product sales and collaboration revenue down. Emflaza lost its orphan drug exclusivity in early 2024, which also contributed to sales falling.

See USP controlled room temperature. Discard any unused Emflaza Oral Suspension remaining after 1 month of first opening the bottle. <2yrs: not recommended. Use oral dispenser. Slowly add into 3 ...

As with other drugs, Emflaza (deflazacort) can cause side effects, such as weight gain and cough. If you are not able to tolerate side effects of Emflaza, talk with your doctor or pharmacist.

The group also took issue with PTC Therapeutics' new steroid drug Emflaza (deflazacort), which has a list price of $90,700, and concluded that when compared to prednisone, deflazacort “is ...

Natixis Advisors LLC purchased a new stake in PTC Therapeutics, Inc. (NASDAQ:PTCT – Free Report) during the fourth quarter, ...

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report)’s share price dropped 8.8% during trading on Monday after JPMorgan ...

Learn more about whether Alvotech or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which ...

PTC Therapeutics, Inc., a biopharmaceutical company ... The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid ...

Learn more about whether Moderna, Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.